BNP PARIBAS FINANCIAL MARKETS - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$5,228,165
-48.6%
51,841
-30.8%
0.01%
-46.2%
Q2 2023$10,173,948
+28.8%
74,869
-1.6%
0.01%
+18.2%
Q1 2023$7,901,357
+50.5%
76,077
+28.5%
0.01%
+37.5%
Q4 2022$5,248,729
-99.9%
59,214
-47.7%
0.01%
-46.7%
Q3 2022$9,075,645,000
+1009.3%
113,205
+1225.0%
0.02%
+1400.0%
Q2 2022$818,173,000
-54.5%
8,544
-29.5%
0.00%
-50.0%
Q1 2022$1,799,535,000
-8.0%
12,114
-12.2%
0.00%
-33.3%
Q4 2021$1,955,154,000
-53.5%
13,792
-57.1%
0.00%
-50.0%
Q3 2021$4,207,100,000
+108.4%
32,157
+118.9%
0.01%
+100.0%
Q2 2021$2,018,709,000
+56.5%
14,689
+48.7%
0.00%
+50.0%
Q1 2021$1,290,229,000
+34.3%
9,880
+15.2%
0.00%0.0%
Q4 2020$960,624,000
+21.6%
8,577
-14.6%
0.00%
+100.0%
Q3 2020$789,847,000
+102.0%
10,040
+84.8%
0.00%0.0%
Q2 2020$391,050,000
-85.3%
5,432
-88.3%
0.00%
-80.0%
Q1 2020$2,659,962,000
+9.6%
46,446
+113.9%
0.01%
+25.0%
Q4 2019$2,428,053,000
+404.6%
21,712
+333.8%
0.00%
+300.0%
Q3 2019$481,231,000
+33.1%
5,005
+18.4%
0.00%0.0%
Q2 2019$361,619,000
-25.5%
4,226
-27.6%
0.00%0.0%
Q1 2019$485,189,000
+310.3%
5,833
+216.7%
0.00%
Q4 2018$118,256,000
+1.2%
1,842
+24.9%
0.00%
Q3 2018$116,850,000
-60.2%
1,475
-63.2%
0.00%
Q2 2018$293,386,000
-46.0%
4,008
-53.3%
0.00%
-100.0%
Q1 2018$543,118,000
-24.3%
8,576
-39.1%
0.00%0.0%
Q4 2017$717,403,000
-3.5%
14,075
-0.6%
0.00%
-50.0%
Q3 2017$743,290,000
+49.9%
14,166
+45.5%
0.00%
+100.0%
Q2 2017$495,850,000
+80.7%
9,734
+57.5%
0.00%0.0%
Q1 2017$274,454,000
-15.5%
6,180
-15.9%
0.00%
-50.0%
Q4 2016$324,738,000
+72.0%
7,352
+56.0%
0.00%
+100.0%
Q3 2016$188,803,000
-55.3%
4,713
-46.8%
0.00%
-50.0%
Q2 2016$422,792,000
+121.0%
8,858
+94.2%
0.00%
+100.0%
Q1 2016$191,288,000
-34.4%
4,561
-31.1%
0.00%0.0%
Q4 2015$291,522,000
-5.0%
6,618
+3.0%
0.00%0.0%
Q3 2015$306,873,000
+84.1%
6,428
+124.7%
0.00%
Q2 2015$166,710,000
+412.7%
2,861
+344.3%
0.00%
Q1 2015$32,516,000
-58.0%
644
-62.6%
0.00%
Q4 2014$77,376,000
-76.9%
1,721
-81.1%
0.00%
Q3 2014$335,465,000
-13.8%
9,106
+3.3%
0.00%
Q2 2014$389,094,000
+18.9%
8,813
+24.8%
0.00%
Q1 2014$327,182,000
+2038.4%
7,062
+1861.7%
0.00%
Q4 2013$15,300,000
-94.0%
360
-95.2%
0.00%
Q3 2013$254,191,000
-15.7%
7,485
-22.4%
0.00%
Q2 2013$301,404,0009,6480.00%
Other shareholders
CONMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders